Bristol-Myers Squibb Co. Live Stock Price Today, Share Analysis and Chart

Name: Bristol-Myers Squibb Co.: Is Infosys Ltd. worth buying?
Item: Bristol-Myers Squibb Co.
Rating: 2.452347375
Author: Trendlyne DVM scores

Value Stock, Under Radar

about

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

45.95 0.59 (1.30%)

27.44% Fall from 52W High

10.0M

XNYS Volume

XNYS 08 Aug, 2025 5:30 PM (EDT)

High Financial Strength

55.6 / 100

Affordable Valuation

55.2 / 100

Technically Bearish

29.9 / 100

Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM

1Yr Price target upside is 16%

21 analysts

Bristol-Myers Squibb Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bristol-Myers Squibb Co. Live Stock Price Today, Share Analysis and Chart

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

27.44% Fall from 52W High

SWOT Analysis

Bristol-Myers Squibb Live Price Chart